VEXAS syndrome: An update.
Khitri MY, Hadjadj J, Mekinian A, Jachiet V.
Joint Bone Spine. 2024 Jul;91(4):105700. doi: 10.1016/j.jbspin.2024.105700. Epub 2024 Feb 1.
[VEXAS Syndrome].
Jachiet V, Comont T, Kosmider O, Zhao LP, Mekinian A, Fain O, Hadjadj J.
Rev Prat. 2025 Feb;75(2):196-200.
Bupropion-induced pancytopenia.
Kim JL, Chercover D, Masoudi H, Foltz L.
BMJ Case Rep. 2024 Nov 26;17(11):e262831. doi: 10.1136/bcr-2024-262831.
Diagnostic difficulties in pernicious anemia.
Oo TH.
Discov Med. 2019 Nov-Dec;28(155):247-253.
Anemia as the Main Manifestation of Myelodysplastic Syndromes.
Santini V.
Semin Hematol. 2015 Oct;52(4):348-56. doi: 10.1053/j.seminhematol.2015.06.002. Epub 2015 Jun 30.
Juvenile myelomonocytic leukemia.
Proytcheva M.
Semin Diagn Pathol. 2011 Nov;28(4):298-303. doi: 10.1053/j.semdp.2011.08.007.
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM, Tefferi A.
Am J Hematol. 2023 Apr;98(4):681-689. doi: 10.1002/ajh.26828. Epub 2023 Jan 4.
Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF, Velloso EDRP, Garanito MP, Leal AM, Siqueira SAC, Azevedo Neto RS, Rocha V, Zerbini MCN.
Ann Diagn Pathol. 2020 Apr;45:151459. doi: 10.1016/j.anndiagpath.2019.151459. Epub 2019 Dec 30.
[Myelodysplastic syndromes].
Thol F, Heuser M, Ganser A.
Internist (Berl). 2015 Apr;56(4):364-73. doi: 10.1007/s00108-014-3598-3.
Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer.
Anampa J, Haque T, Murakhovskaya I, Wang Y, Bachiashvili K, Papazoglu C, Pradhan K, Steidl UG, Sparano JA, Verma A.
Haematologica. 2018 Mar;103(3):e98-e102. doi: 10.3324/haematol.2017.181941. Epub 2017 Nov 30.
